Thread by @Biotech2k1

I am hopeful for biotech in 2022.

I have been a massive bear on biotech all year. I have been calling it a bubble and calling for the $XBI to go to $112 ish. Now that were are hear, I am see hope for the future of biotech.

1/ When I look at the themes I have set my self up for going into the new year, I see areas of the science where next year will unfold data that will either validate or break these themes. That is part of the game of picking biotech stocks.

2/ If these themes work out, then this bear market, we experienced this year, will be a buying opportunity for a life time. I can't say they will work out, but I am very hopeful. Most of these companies are down now 50% to 70% from their peaks.

3/ If this isn't a good time to start buying, then when will it ever be? I look at those themes like AI base drug development, Protein Degraders, Base Editing, iPSC and Synthetic Biology. I see areas of the future that will begin to unfold in 2022 with data.

4/ While everyone else is bearish, I am turning hopeful. I say take the time to do some buying in those companies that will lead the future of biotech while they are beaten down. It might not be the exact bottom here at $112, but its close enough for me.

5/ I have been constantly and consistently deploying cash into any down days for the $XBI. I think there is a lot of bad science out there that looks cheap that might lure you in. I am not here to tell you what to buy just that I think its a good time to do some buying.

6/ I stay stick to the themes that are leading the future. Those are the ones that will lead us out of the bear market first. I personally like:

1. AI based Drug Development
2. Oncology Pathways
3. Protein Degraders
4. iPSC
5. Synthetic Biology
6. Genomics